Natriumklorid Noridem (Sodium Chloride)

Sodium chloride, the active ingredient in Natriumklorid Noridem, is an electrolyte presented as an injection solution for intravenous use. It restores extracellular fluid volume and sodium balance, and is employed in the management of fluid loss, electrolyte disturbances, hypovolemia, and hyponatremia in hospital settings.

GNH USA supplies Natriumklorid Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved products to meet clinical needs across diverse healthcare environments.

Natriumklorid Noridem is used in the fluid and electrolyte replacement pathway to correct volume and sodium deficits. - Fluid replacement: restores intravascular volume in patients with acute fluid loss. - Electrolyte replenishment: normalizes serum sodium chloride concentrations in electrolyte imbalance. - Hypovolemia: increases circulating blood volume to improve tissue perfusion. - Hyponatremia: raises low sodium levels to prevent neurologic complications.

Adverse reactions to intravenous sodium chloride are generally related to the infusion itself or electrolyte shifts. Common Side Effects: - Phlebitis: inflammation and pain at the infusion site. - Hypernatremia: elevated serum sodium if administered in excess, potentially causing neurologic symptoms. - Fluid overload: signs of peripheral edema or pulmonary congestion due to excess volume. - Local irritation: erythema, swelling, or discomfort at the injection site. Serious or Rare Side Effects: - Hyperchloremic metabolic acidosis: disturbance in acid‑base balance with high chloride levels. - Allergic reaction: urticaria, rash, or anaphylaxis requiring immediate medical attention. - Electrolyte imbalance: severe shifts that may precipitate cardiac arrhythmias. - Volume overload leading to heart‑failure exacerbation, especially in patients with compromised cardiac function.

When using Natriumklorid Noridem, clinicians should observe several safety measures to minimize risks. - Assess volume status: evaluate patient’s fluid balance before infusion. - Monitor electrolytes: check serum sodium and chloride levels during therapy. - Adjust infusion rate: use a controlled rate to avoid rapid osmotic shifts. - Caution in renal impairment: reduce volume if kidney function is compromised. - Avoid in severe heart failure: risk of fluid overload. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Sodium chloride may interact with certain medications, influencing fluid and electrolyte balance. Major Interactions (Avoid): - Loop diuretics: can cause excessive sodium loss when combined with high‑dose saline. - Hypertonic glucose solutions: may precipitate hypernatremia if administered concurrently. Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may enhance risk of hyperkalemia when volume status changes. - Lithium therapy: altered renal clearance can increase lithium toxicity. - Anticoagulants: rapid volume expansion may affect plasma concentration, requiring monitoring.